# Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: The First Affiliated Hospital of Soochow University · Condition: Acute Myeloid Leukemia (AML)

- Company: The First Affiliated Hospital of Soochow University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07670130

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.